José-Antonio Arias-Montaño Selected Research

José-Antonio Arias-Montaño Research Topics

Disease

5	Parkinson Disease (Parkinson's Disease) 06/2023 - 10/2004
2	Dyskinesias (Dyskinesia) 06/2023 - 06/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2020
2	Neuroblastoma 04/2018 - 02/2018
1	Obesity 10/2023
1	Urinary Incontinence 10/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Diabetic Cardiomyopathies 10/2021
1	Inflammation (Inflammations) 11/2020
1	Schizophrenia (Dementia Praecox) 11/2020
1	Medulloblastoma 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Temporal Lobe Epilepsy 04/2016
1	Migraine Disorders (Migraine) 09/2013
1	Shy-Drager Syndrome 09/2013
1	Prostatic Neoplasms (Prostate Cancer) 03/2007

Drug/Important Bio-Agent (IBA)

6	Histamine H3 Receptors (Histamine H3 Receptor)IBA 06/2019 - 10/2004
5	Dopamine (Intropin)FDA LinkGeneric 06/2023 - 01/2018
4	Histamine (Histamine Dihydrochloride)FDA Link 04/2016 - 10/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2016
2	LigandsIBA 10/2023 - 01/2020
2	gamma-Aminobutyric Acid (GABA)IBA 06/2023 - 06/2019
2	Levodopa (L Dopa)FDA LinkGeneric 06/2023 - 06/2019
2	Glutamic Acid (Glutamate)FDA Link 06/2023 - 06/2019
2	Protein Isoforms (Isoforms)IBA 01/2022 - 04/2018
2	Oxidopamine (6 Hydroxydopamine)IBA 06/2019 - 02/2018
2	Amino Acids FDA Link 04/2018 - 09/2013
1	CholesterolIBA 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	Triglycerides (Triacylglycerol)IBA 10/2023
1	Messenger RNA (mRNA)IBA 06/2023
1	Presenilin-1IBA 01/2022
1	Cathepsin DIBA 01/2022
1	Phosphotransferases (Kinase)IBA 10/2021
1	Protein Kinases (Protein Kinase)IBA 10/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2020
1	Particulate MatterIBA 11/2020
1	4-(1H-imidazol-4-ylmethyl)piperidineIBA 06/2019
1	Dialysis SolutionsIBA 06/2019
1	Ifosfamide FDA LinkGeneric 01/2019
1	EnzymesIBA 01/2019
1	CytochromesIBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Cytochrome P-450 CYP3AIBA 01/2019
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2019
1	IonsIBA 04/2018
1	ColforsinIBA 04/2018
1	clobenpropitIBA 02/2018
1	tele-methylhistamineIBA 04/2016
1	Guanine NucleotidesIBA 04/2016
1	Valine (L-Valine)FDA Link 09/2013
1	Alanine (L-Alanine)FDA Link 09/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2012
1	Histamine Receptors (Histamine Receptor)IBA 03/2007
1	Cyclic AMP (AMP, Cyclic)IBA 03/2007
1	AndrogensIBA 03/2007
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 03/2007
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2007

Therapy/Procedure

1	Therapeutics 10/2023